Related Experiment Videos
Thoracic neuroblastoma: a Pediatric Oncology Group study
G A Adams1, S J Shochat, E I Smith
1Stanford University Medical Center, CA.
Journal of Pediatric Surgery
|March 1, 1993
Summary
Thoracic neuroblastoma in children shows a favorable prognosis, with most patients presenting young with localized disease. Combined modality therapy offers an excellent outlook, even if complete surgical resection isn't achieved.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Neuroblastoma Research
Background:
- Thoracic neuroblastoma is a rare but significant pediatric malignancy.
- Understanding its unique characteristics and treatment outcomes is crucial for improving patient care.
Purpose of the Study:
- To prospectively evaluate the clinical presentation, management, and outcomes of pediatric patients with thoracic neuroblastoma.
- To investigate factors influencing survival and determine optimal therapeutic strategies.
Main Methods:
- Prospective study of 96 patients with thoracic neuroblastoma.
- Analysis of clinical data including age, disease stage, presenting symptoms, diagnostic methods, surgical interventions, complications, and survival rates.
- Long-term follow-up for 75 patients (over 4 years).
Main Results:
- Median age at presentation was 0.9 years; 48% presented with stage A disease.
- Posterior mediastinal mass diagnosed incidentally in 49%; 16% had neurological symptoms, 14% respiratory distress.
- Elevated urinary catecholamines in 76%; 88% overall actuarial survival at 4 years.
- Complete surgical resection in 47%; minor complications in 20%, significant in 3%.
Conclusions:
- Thoracic neuroblastomas have a favorable prognosis in children, often presenting with localized disease and better survival than other neuroblastoma sites.
- Complete surgical excision is recommended but not always essential; combined modality therapy yields excellent outcomes.
- The biology of thoracic neuroblastomas appears distinct, warranting tailored treatment approaches.